Dotan Shaniv, Anne Smits, Karel Allegaert, & on behalf of the Neonatal Drug Formularies Group. (2024). Reply to Garnemark et al. The Swedish National Formulary for Children ePed. Comment on "Shaniv et al. A Callout for International Collaboration. Reply to Giger, E.V.; Tilen, R. Comment on "Shaniv et al. Neonatal Drug Formularies-A Global Scope. <i>Children</i> 2023, <i>10</i>, 848". <i>Children</i> 2023, <i>10</i>, 1803". MDPI AG.
Chicago Style (17th ed.) CitationDotan Shaniv, Anne Smits, Karel Allegaert, and on behalf of the Neonatal Drug Formularies Group. Reply to Garnemark Et Al. The Swedish National Formulary for Children EPed. Comment on "Shaniv Et Al. A Callout for International Collaboration. Reply to Giger, E.V.; Tilen, R. Comment on "Shaniv Et Al. Neonatal Drug Formularies-A Global Scope. <i>Children</i> 2023, <i>10</i>, 848". <i>Children</i> 2023, <i>10</i>, 1803". MDPI AG, 2024.
MLA (9th ed.) CitationDotan Shaniv, et al. Reply to Garnemark Et Al. The Swedish National Formulary for Children EPed. Comment on "Shaniv Et Al. A Callout for International Collaboration. Reply to Giger, E.V.; Tilen, R. Comment on "Shaniv Et Al. Neonatal Drug Formularies-A Global Scope. <i>Children</i> 2023, <i>10</i>, 848". <i>Children</i> 2023, <i>10</i>, 1803". MDPI AG, 2024.